Gastric mucosal blood flow changes in Helicobacter pylori infection and NSAID-induced gastric injury

Helicobacter

Volumn 8, Issue 2, 2003, Pages 124-131

  Elizalde, J Ignasi ^a   Mendez, Asuncion ^b   Gomez, Julia ^c   Del Rivero, Maria ^b   Gironella, Meritxell ^a   Closa, Daniel ^a   Quintero, Enrique ^b   Pique, Josep M ^a,c  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^b HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

Author keywords

Gastric mucosal blood flow; Helicobacter pylori; Nitric oxide; NSAID

Indexed keywords

INDOMETACIN; MYELOPEROXIDASE; NITRIC OXIDE; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; DISEASE EXACERBATION; DRUG INDUCED DISEASE; ELECTROCHEMICAL ANALYSIS; ENZYME ACTIVITY; GASTRITIS; HELICOBACTER PYLORI; HYDROGEN CLEARANCE; HYPEREMIA; INOCULATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STOMACH BLOOD FLOW; STOMACH INJURY; STOMACH MUCOSA;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; GASTRIC MUCOSA; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; INDOMETHACIN; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NITRIC OXIDE; PEROXIDASE; REGIONAL BLOOD FLOW;

ANIMALIA; HELICOBACTER; HELICOBACTER PYLORI;

EID: 0242584414     PISSN: 10834389     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-5378.2003.00133.x     Document Type: Article

References (44)

1. Pique JM, Leung FW, Tan HW, Livingston E, Scremin OU, Guth PH. Gastric mucosal blood flow response to stimulation and inhibition of gastric acid secretion. Gastroenterology 1988;95:642-50.
2. Kawano S, Tsuji S. Role of mucosal blood flow: a conceptional review in gastric mucosal injury and protection. J Gastroenterol Hepatol 2000;15:D1-6.
3. Casadevall M, Pique JM, Cirera I, Barrachina MD, Teres J. Acute normovolaemic anaemia prevents ethanol-induced gastric damage in rats through a blood flow related mechanism. Naunyn Schmiedebergs Arch Pharmacol 1994;350:569-74.
4. Brzozowski T, Konturek PC, Sliwowski Z, et al. Lypopolysaccharide of Helicobacter pylori protects gastric mucosa via generation of nitric oxide. J Physiol Pharmacol 1997;48:699-717.
5. Huang JQ, Sridhar S, Hunt RH. Role of Helicobacter pylori infection and nonsteroidal antiinflammatory drugs in peptic-ulcer disease: a meta-analysis. Lancet 2002;359:14-22.
6. Hawkey CJ, Tulassay Z, Szczepanski L et al. Randomised controlled trial of Helicobacter pylori eradication in patients in nonsteroidal antiinflammatory drugs. HELP NSAID Study. Lancet 1998;352:1016-21.
7. Chan FK, To KF, Wu JC, et al. Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with nonsteroidal anti-inflammatory drugs: a randomised trial. Lancet 2002;359:9-13.
8. Fu S, Ramanujam KS, Wong A, et al. Increased expression and cellular localization of inducible nitric oxide synthase and cyclooxygenase 2 in Helicobacter pylori gastritis. Gastroenterology 1999;116:1319-29.
9. Pique JM, Whittle BJ, Esplugues JV. The vasodilator role of endogenous nitric oxide in the rat gastric microcirculation. Eur J Pharmacol 1989;174:293-6.
10. Kiss J, Lamarque D, Moran AP, et al. Helicobacter pylori lipopolysaccharide-provoked injury to rat gastroduodenal microvasculature involves inducible nitric oxide synthase. Eur J Pharmacol 2001;420:175-9.
11. Takeuchi K, Mizoguchi H, Araki H, Komoike Y, Suzuki K. Lack of gastric toxicity of nitric oxidereleasing indomethacin, NCX-530, in experimental animals. Dig Dis Sci 2001;46:1805-18.
12. Lee A, O'Rourke J, De Ungria MC, Robertson B, Daskalopoulos G, Dixon MF. A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain. Gastroenterology 1997;112:1386-97.
13. Ferrero RL, Thiberge JM, Huerre M, Labigne A. Immune responses of specific-pathogen-free mice to chronic Helicobacter pylori (strain SS1) infection. Infect Immun 1998;66:1349-55.
14. van Doorn NE, Namavar F, Sparrius M, et al. Helicobacter pylori-associated gastritis in mice is host and strain specific. Infect Immun 1999;67:3040-6.
15. Marchetti M, Arico B, Burroni D, Figura N, Rappuoli R, Ghiara P. Development of a mouse model of Helicobacter pylori infection that mimics human disease. Science 1995;267:1655-8.
16. Elizalde JI, Gomez J, Panes J, et al. Platelet activation in mice and human Helicobacter pylori infection. J Clin Invest 1997;100:996-1005.
17. Bayerdorffer E, Lehn N, Hatz R, et al. Difference in expression of Helicobacter pylori gastritis in antrum and body. Gastroenterology 1992;102:1575-82.
18. Mendez A, Casadevall M, Wachter CH, et al. Gastric mucosal blood flow regulation in response to different stimuli. Dig Dis Sci 1997;42:1873-9.
19. Mendez A, Fernandez M, Barrios Y, et al. Constitutive NOS isoforms account for gastric mucosal NO overproduction in uremic rats. Am J Physiol 1997;272:G894-901.
20. Malinski T, Taha Z. Nitric oxide release from a single cell measured in situ by a porphyrinicbased microsensor. Nature 1992;358:676-8.
21. Gonzalez-Mora JL, Guadalupe T, Fumero B, Mas M. Mathematical resolution of mixed in vivo voltametry signals. Models, equipment, assessment by simultaneous microdyalisis sampling. J Neurosci Meth 1991;39:231-44.
22. Morise Z, Komatsu S, Fuseler JW, et al. ICAM-1 and P-selectin expression in a model of NSAID-induced gastropathy. Am J Physiol 1998;274:G246-52.
23. Sans M, Salas A, Soriano A, et al. Differential role of selectins in experimental colitis. Gastroenterology 2001;120:1162-72.
24. Takahashi S, Fujita T, Yamamoto A. Nonsteroidal anti-inflammatory drug-induced acute gastric injury in Helicobacter pylori gastritis in Mongolian gerbils. Eur J Pharmacol 2000;406:461-8.
25. Yoshida N, Sugimoto N, Hirayama F, et al. Helicobacter pylori infection potentiates aspirin induced gastric mucosal injury in Mongolian gerbils. Gut 2002;50:594-8.
26. Sugiyama A, Ikeno T, Ishida K, et al. Paradoxical role of Helicobacter pylori infection: protective effect against ethanol-induced gastric mucosal injury in Mongolian gerbils. Dig Dis Sci 2001;46:2433-9.
27. Schraier M, Petrelli L, Bonfanti M, et al. Experimental model of infection of Helicobacter pylori in the mouse. A study of gastric damage caused by indomethacin. Acta Gastroenterol Latinoam 2001;31:115-21.
28. Wallace JL. Nonsteroidal anti-inflammatory drugs and gastroenteropathy: the second hundred years. Gastroenterology 1997;112:1000-16.
29. Calatayud S, Sanz MJ, Canet A, Bello R, de Rojas FD, Esplugues JV. Mechanisms of gastroprotection by transdermal nitroglycerin in the rat. Br J Pharmacol 1999;127:1111-8.
30. Marroni N, Casadevall M, Panes J, Piera C, Jou JM, Pique JM. Effects of chronic normovolemic anemia on gastric microcirculation and ethanol-induced gastric damage in rats. Dig Dis Sci 1994;39:751-7.
31. Wallace JL, Keenan CM, Granger DN. Gastric ulceration induced by nonsteroidal anti-inflammatory drugs is a neutrophil-dependent process. Am J Physiol 1990;259:G462-7.
32. Beck PL, Xavier R, Lu N, et al. Mechanisms of NSAID-induced gastrointestinal injury defined using mutant mice. Gastroenterology 2000;119:699-705.
33. Shimoyama T, Fukuda S, Liu Q, Nakaji S, Fukuda Y, Sugawara K. Production of chemokines and reactive oxygen species by human neutrophils stimulated with Helicobacter pylori. Helicobacter 2002;3:170-4.
34. Salas A, Panés J, Piqué JM. Estrés oxidativo y daño gastrointestinal. Gastroenterol Hepatol 1999;22:309-17.
35. von Bothmer C, Edebo A, Lonroth H, Olbe L, Pettersson A, Fandriks L. Helicobacter pylori infection inhibits antral mucosal nitric oxide production in humans. Scand J Gastroenterol 2002;37:404-8.
36. Gobert AP, McGee DJ, Akhtar M, et al. Helicobacter pylori arginase inhibits nitric oxide production by eukaryotic cells: a strategy for bacterial survival. Proc Natl Acad Sci USA 2001;98:13844-9.
37. Eiserich JP, Baldus S, Brennan ML, et al. Myeloperoxidase, a leukocyte-derived vascular NO oxidase. Science 2002;296:2391-4.
38. Atuma C, Engstrand L, Holm L. Helicobacter pylori extracts reduce gastric mucosal blood flow by a nitric oxide-independent but mast cell- and platelet-activating factor receptordependent pathway in rats. Scand J Gastroenterol 1999;34:1183-9.
39. Kalia N, Jacob S, Brown NJ, Reed MW, Morton D, Bardhan KD. Studies on the gastric mucosal microcirculation. 2. Helicobacter pylori water soluble extracts induce platelet aggregation in the gastric mucosal microcirculation in vivo. Gut 1997;41:748-52.
40. Miyazaki SM, Matsuda MG, Misumi A, et al. Blood flow, acidity and atrophic changes of the gastric mucosa in Mongolian gerbils infected with Helicobacter pylori. Digest Endosc 2001;13:195- 201.
41. Taha AS, Angerson W, Nakshabendi I, et al. Gastric and duodenal mucosal blood flow in patients receiving nonsteroidal anti-inflammatory drugs. Influence of age, smoking, ulceration and Helicobacter pylori. Aliment Pharmacol Ther 1993;7:41-5.
42. Lipscomb GR, Wallis N, Armstrong G, Goodman MJ, Rees WD. Influence of Helicobacter pylori on gastric mucosal adaptation to naproxen in man. Dig Dis Sci 1996;41:1583-8.
43. Guslandi M, Sorghi M, Tittobello A. Does Helicobacter pylori affect gastric microcirculation? Ital J Gastroenterol 1994;26:383-4.
44. Chang FKL, Chung S, Suen BY, et al. Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen. N Engl J Med 2001;344:967-73.